Successful treatment of an urgent dialysis patient with uremic encephalopathy


  • Felicity P. Marthadinata Department of Internal Medicine, Wangaya Regional General Hospital, Bali, Indonesia
  • I Dewa Gede Amara Putra Wibawa Department of Internal Medicine, Wangaya Regional General Hospital, Bali, Indonesia
  • I Wayan Sunaka Department of Internal Medicine, Wangaya Regional General Hospital, Bali, Indonesia



Diabetes, End-stage renal disease, Uremic encephalopathy, Urgent dialysis


Diabetes has become a global pandemic and is believed to be one of the most common risk factors for chronic kidney disease, which leads to end-stage renal disease, of which a significant number will develop, requiring renal replacement therapy. Uremic encephalopathy is the most frequent complication of untreated chronic kidney disease, is defined as cerebral dysfunction due to toxin accumulation. If this occurs, renal replacement therapy, which is urgent dialysis, is essential for lowering the patient's mortality. We report a 48-year-old female patient with uncontrolled type 2 diabetes who presented with delirium, poor physical performance and muscle mass loss.


KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International. 2022;102(5S):S1-S127.

Lin YC, Chang YH, Yang SY, Wu KD, Chu TS. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117(8):662-75.

Martins JM, Magriço R. Uremic Frost in End-Stage Renal Disease. N Engl J Med. 2018;379(7):669.

McGrath K, Edi R. Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention. Am Fam Physician. 2019;99(12):751-9.

Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complication of chronic kidney disease: current state, knowledge gaps, and strategy action. Kidney Int Suppl. 2017;7:122-9.

Boer IH, Khunti K., Sadusky T., Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the american diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO). Diabetes Care. 2022;45(12):3075-90.

Hassan EM, Mushtaq H, Mahmoud EE, Chhibber S, Saleem S, Issa A, et al. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state. World J Clin Cases. 2022;10(32):11702-11.

Rosner MH, Faeq HS, Reis T, Ronco C, Vanholder R. Uremic encephalopathy. Kidney International. 2022;101(2):227-41.

Sterns RH, Silver SM, Hix JK. Urea for hyponatremia? Kidney Int. 2015;87(2):268-70.

Granado RCD, Macedo, E. Indication and timing of renal replacemenet therapy. Gac Med Mex. 2018;1:15-21.

Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240-25.

Lee J, Kim SG, Yun D, Kang MW, Kim YC, Kim DK, et al. Consulting to nephrologist when starting continuous renal replacement therapy for acute kidney injury is associated with a survival benefit. PLoS One. 2023;18(2):e0281831.






Case Reports